A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Phase of Trial: Phase II
Latest Information Update: 17 Mar 2017
At a glance
- Drugs Olumacostat glasaretil (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Dermira
- 17 Mar 2017 According to a Dermira media release, data from this study will be presented at 13th Annual Maui Derm for Dermatologists 2017 meeting.
- 03 Mar 2017 Results published in a Dermira media release.
- 03 Mar 2017 According to a Dermira media release, new data were presented in poster sessions at the 75th Annual Meeting of the American Academy of Dermatology (AAD).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History